肿瘤科威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 肿瘤科威廉亚洲博彩公司

铂类药物临床应用与不良反应管理专家共识

2018-05-23 广东省药学会 广东省药学会官网

铂类药物临床应用不良反应

铂类药物开发于20世纪60年代，属于细胞周期非特异性药物，主要通过进入肿瘤细胞后与DNA 形成Pt-DNA加合物，从而介导肿瘤细胞坏死或凋亡，进而产生抗癌效果。铂类药物因其独特的抗癌机制和广泛的抗癌谱，成为目前临床上使用最广的化疗药物之一，作为基本药物被广泛用于肺癌、膀胱癌、卵巢癌、宫颈癌、食管癌、胃癌、结直肠癌和头颈部肿瘤等常见恶性肿瘤的治疗。为了促进药师进入临床团队，规范铂类药物在临床上的使用

中文标题：

铂类药物临床应用与不良反应管理专家共识

发布机构：

广东省药学会

发布日期：

2018-05-23

简要介绍：

铂类药物开发于20世纪60年代，属于细胞周期非特异性药物，主要通过进入肿瘤细胞后与DNA 形成Pt-DNA加合物，从而介导肿瘤细胞坏死或凋亡，进而产生抗癌效果。铂类药物因其独特的抗癌机制和广泛的抗癌谱，成为目前临床上使用最广的化疗药物之一，作为基本药物被广泛用于肺癌、膀胱癌、卵巢癌、宫颈癌、食管癌、胃癌、结直肠癌和头颈部肿瘤等常见恶性肿瘤的治疗。为了促进药师进入临床团队，规范铂类药物在临床上的使用，广东省药学会组织省内医疗机构专家通过分析临床常用铂类药物的药学特点，制定了该类药物临床应用与不良反应管理专家共识。 

拓展威廉亚洲博彩公司 ：与铂类药物相关威廉亚洲博彩公司 ：

相关资料下载：
[AttachmentFileName(sort=100, fileName=铂类药物临床应用与不良反应管理专家共识)] GetToolGuiderByIdResponse(projectId=1, id=78e141c00159651c, title=铂类药物临床应用与不良反应管理专家共识, enTitle=, guiderFrom=广东省药学会官网, authorId=null, author=, summary=铂类药物开发于20世纪60年代，属于细胞周期非特异性药物，主要通过进入肿瘤细胞后与DNA 形成Pt-DNA加合物，从而介导肿瘤细胞坏死或凋亡，进而产生抗癌效果。铂类药物因其独特的抗癌机制和广泛的抗癌谱，成为目前临床上使用最广的化疗药物之一，作为基本药物被广泛用于肺癌、膀胱癌、卵巢癌、宫颈癌、食管癌、胃癌、结直肠癌和头颈部肿瘤等常见恶性肿瘤的治疗。为了促进药师进入临床团队，规范铂类药物在临床上的使用, cover=, journalId=null, articlesId=null, associationId=1082, associationName=广东省药学会, associationIntro=广东省药学会前身为1945年成立的广州药师公会，1951年成为中国药学会广州分会。1958年在原有基础上扩大组织，成立中国药学会广东分会，负责组织全省药学科技工作者的相关活动。1985年起，中国药学会广东分会一直挂靠在广东省食品药品监督管理局（省医药管理局）。1991年，按民政部门文件要求更名为广东省药学会。, copyright=0, guiderPublishedTime=Wed May 23 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>铂类药物开发于20世纪60年代，属于细胞周期非特异性药物，主要通过进入肿瘤细胞后与DNA 形成Pt-DNA加合物，从而介导肿瘤细胞坏死或凋亡，进而产生抗癌效果。铂类药物因其独特的抗癌机制和广泛的抗癌谱，成为目前临床上使用最广的化疗药物之一，作为基本药物被广泛用于肺癌、膀胱癌、卵巢癌、宫颈癌、食管癌、胃癌、结直肠癌和头颈部肿瘤等常见恶性肿瘤的治疗。为了促进药师进入临床团队，规范铂类药物在临床上的使用，广东省药学会组织省内医疗机构专家通过分析临床常用铂类药物的药学特点，制定了该类药物临床应用与不良反应管理专家共识。 </div> <div><br> </div> 拓展威廉亚洲博彩公司 ：<strong>与<font color=red>铂类药物</font>相关威廉亚洲博彩公司 ：</strong><br><ul><li><a href="//www.nyrain.com/guideline/show_article.do?id=78e141c00159651c" title="铂类药物临床应用与不良反应管理专家共识" target=_blank>铂类药物临床应用与不良反应管理专家共识</a></li> 更多信息请点击：<a href="//www.nyrain.com/guideline/list.do?q=%E9%93%82%E7%B1%BB%E8%8D%AF%E7%89%A9" target=_blank>有关铂类药物更多威廉亚洲博彩公司 </a></ul>, tagList=[TagDto(tagId=40523, tagName=铂类药物), TagDto(tagId=611, tagName=临床应用), TagDto(tagId=795, tagName=不良反应)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4931, appHits=302, showAppHits=0, pcHits=2990, showPcHits=2517, likes=87, shares=11, comments=5, approvalStatus=1, publishedTime=Sat May 26 22:22:37 CST 2018, publishedTimeString=2018-05-23, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat May 26 22:22:37 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 03:22:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=铂类药物临床应用与不良反应管理专家共识)])
铂类药物临床应用与不良反应管理专家共识
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2119427, encodeId=71bb211942e20, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKU4B2MceUmMlO5n2ksKqS1l2VdYwskjN79GACsjb6m7IOmNRj1AiaianDSPL5SYR9l6z5xKoV78ahw/132, createdBy=7e345141477, createdName=Luciano, createdTime=Tue Mar 14 22:48:27 CST 2023, time=2023-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912327, encodeId=6d5791232e48, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84ef5281836, createdName=14844f65m93暂无昵称, createdTime=Wed Dec 30 21:44:45 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321252, encodeId=9fd732125235, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sun Jun 03 23:37:38 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318877, encodeId=ad133188e786, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun May 27 05:19:02 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
    2023-03-14 Luciano

    谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2119427, encodeId=71bb211942e20, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKU4B2MceUmMlO5n2ksKqS1l2VdYwskjN79GACsjb6m7IOmNRj1AiaianDSPL5SYR9l6z5xKoV78ahw/132, createdBy=7e345141477, createdName=Luciano, createdTime=Tue Mar 14 22:48:27 CST 2023, time=2023-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912327, encodeId=6d5791232e48, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84ef5281836, createdName=14844f65m93暂无昵称, createdTime=Wed Dec 30 21:44:45 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321252, encodeId=9fd732125235, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sun Jun 03 23:37:38 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318877, encodeId=ad133188e786, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun May 27 05:19:02 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
    2020-12-30 14844f65m93暂无昵称

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2119427, encodeId=71bb211942e20, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKU4B2MceUmMlO5n2ksKqS1l2VdYwskjN79GACsjb6m7IOmNRj1AiaianDSPL5SYR9l6z5xKoV78ahw/132, createdBy=7e345141477, createdName=Luciano, createdTime=Tue Mar 14 22:48:27 CST 2023, time=2023-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912327, encodeId=6d5791232e48, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84ef5281836, createdName=14844f65m93暂无昵称, createdTime=Wed Dec 30 21:44:45 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321252, encodeId=9fd732125235, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sun Jun 03 23:37:38 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318877, encodeId=ad133188e786, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun May 27 05:19:02 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
    2018-06-03 清风拂面

    谢谢分享学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2119427, encodeId=71bb211942e20, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKU4B2MceUmMlO5n2ksKqS1l2VdYwskjN79GACsjb6m7IOmNRj1AiaianDSPL5SYR9l6z5xKoV78ahw/132, createdBy=7e345141477, createdName=Luciano, createdTime=Tue Mar 14 22:48:27 CST 2023, time=2023-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912327, encodeId=6d5791232e48, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84ef5281836, createdName=14844f65m93暂无昵称, createdTime=Wed Dec 30 21:44:45 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321252, encodeId=9fd732125235, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sun Jun 03 23:37:38 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318877, encodeId=ad133188e786, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun May 27 05:19:02 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
    2018-05-27 飛歌

    厉害了我的哥

    0